Comment on: "Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis"

Hum Vaccin Immunother. 2024 Dec 31;20(1):2398870. doi: 10.1080/21645515.2024.2398870. Epub 2024 Oct 21.
No abstract available

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.